More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
This article was originally published in The Tan Sheet
Executive Summary
FDA supplement program official Daniel Fabricant says firms that fail to use appropriate tests for botanical ingredients are at risk of eliciting warning letters and other agency actions for violating GMPs. AHP’s Roy Upton says he sees FDA’s botanical expertise outpacing industry’s.